Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics today announced an agreement with an unnamed institutional investor to restructure its secured debt with former shareholders of RedPath, and to terminate its royalty and milestone obligations.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.